Statins Are Associated With a Decreased Risk of Severe Liver Disease in Individuals With Noncirrhotic Chronic Liver Disease.

MLA

Sharma, Rajani, et al. “Statins Are Associated With a Decreased Risk of Severe Liver Disease in Individuals With Noncirrhotic Chronic Liver Disease.” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, vol. 22, no. 4, Apr. 2024, p. 749. EBSCOhost, https://doi.org/10.1016/j.cgh.2023.04.017.

APA

Sharma, R., Simon, T. G., Hagström, H., Lochhead, P., Roelstraete, B., Söderling, J., Verna, E. C., Emond, J., & Ludvigsson, J. F. (2024). Statins Are Associated With a Decreased Risk of Severe Liver Disease in Individuals With Noncirrhotic Chronic Liver Disease. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, 22(4), 749. https://doi.org/10.1016/j.cgh.2023.04.017

Chicago

Sharma, Rajani, Tracey G Simon, Hannes Hagström, Paul Lochhead, Bjorn Roelstraete, Jonas Söderling, Elizabeth C Verna, Jean Emond, and Jonas F Ludvigsson. 2024. “Statins Are Associated With a Decreased Risk of Severe Liver Disease in Individuals With Noncirrhotic Chronic Liver Disease.” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 22 (4): 749. doi:10.1016/j.cgh.2023.04.017.